Addus HomeCare (NASDAQ:ADUS) Price Target Raised to $128.00 at TD Cowen

Addus HomeCare (NASDAQ:ADUS) had its price target increased by TD Cowen from $119.00 to $128.00 in a research note issued to investors on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock.

Several other equities research analysts have also recently weighed in on the stock. StockNews.com upgraded shares of Addus HomeCare from a buy rating to a strong-buy rating in a research note on Thursday, June 6th. Bank of America raised their price target on shares of Addus HomeCare from $115.00 to $118.00 and gave the stock a buy rating in a research note on Tuesday, May 7th. Stephens raised their price target on shares of Addus HomeCare from $120.00 to $128.00 and gave the stock an overweight rating in a research note on Friday, May 31st. Barclays cut shares of Addus HomeCare from an equal weight rating to an underweight rating and set a $83.00 price target for the company. in a research note on Tuesday, April 23rd. Finally, Oppenheimer raised their price target on shares of Addus HomeCare from $118.00 to $130.00 and gave the stock an outperform rating in a research note on Friday, June 7th. One equities research analyst has rated the stock with a sell rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of Moderate Buy and a consensus price target of $113.43.

Addus HomeCare Trading Up 1.4 %

Addus HomeCare stock opened at $119.30 on Tuesday. The stock has a market cap of $1.95 billion, a P/E ratio of 29.60, a P/E/G ratio of 2.22 and a beta of 1.02. Addus HomeCare has a 12 month low of $78.35 and a 12 month high of $119.98. The company’s fifty day simple moving average is $106.40 and its 200-day simple moving average is $98.52. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.14.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The company had revenue of $280.70 million during the quarter, compared to analysts’ expectations of $279.49 million. During the same period in the prior year, the company earned $0.84 earnings per share. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. As a group, sell-side analysts forecast that Addus HomeCare will post 4.36 EPS for the current fiscal year.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of Addus HomeCare stock in a transaction on Monday, June 17th. The shares were sold at an average price of $116.13, for a total transaction of $25,200.21. Following the completion of the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,186,500.21. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 4.60% of the stock is currently owned by company insiders.

Institutional Trading of Addus HomeCare

A number of institutional investors have recently bought and sold shares of ADUS. Swiss National Bank lifted its position in Addus HomeCare by 1.4% in the 3rd quarter. Swiss National Bank now owns 35,600 shares of the company’s stock valued at $3,033,000 after acquiring an additional 500 shares in the last quarter. Janney Montgomery Scott LLC grew its position in shares of Addus HomeCare by 5.5% during the 3rd quarter. Janney Montgomery Scott LLC now owns 10,933 shares of the company’s stock worth $932,000 after purchasing an additional 573 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of Addus HomeCare by 3.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,243 shares of the company’s stock worth $14,247,000 after purchasing an additional 5,225 shares in the last quarter. HighTower Advisors LLC bought a new stake in shares of Addus HomeCare during the 3rd quarter worth approximately $455,000. Finally, Deutsche Bank AG lifted its holdings in shares of Addus HomeCare by 15.3% during the 3rd quarter. Deutsche Bank AG now owns 9,353 shares of the company’s stock worth $797,000 after acquiring an additional 1,243 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.